Evidence map›Paper›PMID 41444986›Full record

ArticleParticle and fibre toxicology2025

Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles.

Freddy G Ganse, Lena M Ernst, Cristina Rodríguez, Marisol Ruiz-Meana, Javier Inserte, José Martínez-González, Ana M Briones, Ana Belén García-Redondo, Marta Consegal, Elisabet Miró-Casas and 7 more

Abstract read
In one paragraph

Article in Particle and fibre toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Freddy G GanseCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Lena M ErnstDisseny i Farmacodinàmica de Nanopartícules, Vall d'Hebron Research Institute, Barcelona, Spain.
Cristina RodríguezCIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Marisol Ruiz-MeanaCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Javier InserteCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
José Martínez-GonzálezCIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Ana M BrionesCIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Ana Belén García-RedondoCIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Marta ConsegalCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Elisabet Miró-CasasCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Laia Yáñez-BisbeCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Aitor PomposoCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Marta Prades-MartínezCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Ignacio Ferreira-GonzálezCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain.
Victor PuntesDisseny i Farmacodinàmica de Nanopartícules, Vall d'Hebron Research Institute, Barcelona, Spain. victor.puntes@vhir.org.
Begoña BenitoCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain. begona.benito@vhir.org.
Antonio Rodríguez-SinovasCardiovascular Diseases Research Group, Vall d'Hebron Research Institute (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119, 08035, Barcelona, Spain. antonio.rodriguez.sinovas@vhir.org.

Funding

European Regional Development Fund ERDF-FEDERGeneralitat de Catalunya PERIS STL028/23/00195Instituto de Salud Carlos III CIBERCVInstituto de Salud Carlos III PI20/01649Ministerio de Ciencia e Innovación FORTALECE-FORT23/0034
6 · The paper itself

Abstract

backgroundEpidemiological studies suggest an association between air pollution and ventricular arrhythmias, with reactive oxygen species (ROS) playing a crucial role. However, the causal relationship and long-term effects remain uncertain, and the effectiveness of interventions aimed at reducing ROS requires further investigation. Here we aimed to evaluate the effects of a 3-weeks exposure to diesel exhaust particles (DEPs) on ventricular arrhythmogenesis, explore the underlying mechanisms, and assess the potential of cerium oxide nanoparticles (CeO

resultsSprague-Dawley rats underwent intratracheal instillation of saline without or with DEPs (7.5 g/Kg for 1-3 weeks). Ventricular arrhythmia inducibility was then assessed in isolated hearts using a protocol of programmed electrical stimulation. Cardiac hypertrophy, collagen content, inflammation and oxidative stress were analyzed using histology, Western blot, RT-qPCR, and measurement of malondialdehyde content. The potential protective effects of CeO

conclusionsDEP exposure increases the incidence and duration of sustained VTs, collagen deposition and oxidative stress in rats. Treatment with CeO

Indexed as

AntioxidantsArrhythmias, CardiacCeriumNanoparticlesParticulate MatterVehicle EmissionsAnimalsMaleOxidative StressRatsRats, Sprague-DawleyAntioxidantsceric oxideCeriumParticulate MatterVehicle EmissionsAir pollutionCerium oxideFibrosisOxidative stressVentricular arrhythmias

Identifiers

PMID41444986
PMCPMC12739854

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.